BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. (Q51063349)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Umberto Cillo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Fabio Farinati

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Veronica Vanin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Anna Giacomin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Caterina Pozzan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Alessandro Vitale

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Anna Maria Di Nolfo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Paolo Del Poggio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Luisa Benvegnu'

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Gianludovico Rapaccini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Marco Zoli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Franco Borzio

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Eugenio Caturelli

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Franco Trevisani

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Italian Liver Cancer (ITA.LI.CA) group

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

27 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

223-231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

11 March 2020

cites work

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma

21 January 2018

1 reference

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

21 January 2018

1 reference

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).

21 January 2018

1 reference

A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma

21 January 2018

1 reference

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

21 January 2018

1 reference

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.

21 January 2018

1 reference

Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead

21 January 2018

1 reference

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

21 January 2018

1 reference

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

21 January 2018

1 reference

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

21 January 2018

1 reference

Chemoembolization and radioembolization for hepatocellular carcinoma.

21 January 2018

1 reference

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

21 January 2018

1 reference

Performance status assessment in cancer patients. An inter-observer variability study

21 January 2018

1 reference

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

21 January 2018

1 reference

Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

21 January 2018

1 reference

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients

21 January 2018

1 reference

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

21 January 2018

1 reference

Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12649

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25074434%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference